Sepehripour A H, Saso S, Harling L, Punjabi P, Ashrafian H, Athanasiou T
Department of Surgery and Cancer, Imperial College London, UK.
Perfusion. 2013 Jul;28(4):340-9. doi: 10.1177/0267659113482173. Epub 2013 Mar 21.
Re-operative coronary artery bypass grafting (CABG) is a challenging operation that is often performed in a high-risk patient group. Avoiding cardiopulmonary bypass (CPB) in these patients is hypothesised to be advantageous due to the reduced invasiveness and physiological stress of off-pump coronary artery bypass grafting (OPCAB). The aims of this study were to assess whether OPCAB may improve outcomes in patients undergoing re-operative CABG.
Twelve studies, incorporating 3471 patients, were identified by systematic literature review. These were meta-analysed using random-effects modelling. Primary endpoints were 30-day and mid-term mortality. Secondary endpoints were completeness of revascularization, mean number of grafts per patient and the effect of intra-operative conversion on mortality.
A significantly lower rate of 30-day mortality was observed with OPCAB (OR 0.51, 95% CI [0.35, 0.74]), however, no difference was demonstrated in mid-term mortality. Significantly less complete revascularization and mean number of grafts per patient were observed in the OPCAB group. Meta-regression revealed no change in 30-day mortality when the effect of conversion from one technique to the other was assessed.
Off-pump techniques may reduce early mortality in selected patients undergoing re-operative CABG; however, this does not persist into mid-term follow-up. OPCAB may also lead to intra-operative conversion and, although this did not affect outcomes in this study, these results are constrained by the limited data available. Furthermore, OPCAB may increase target vessel revascularization and, consequently, incomplete revascularization which, whilst not reflected in the short-term outcomes, requires longer-term follow-up in order to be fully assessed.
再次冠状动脉旁路移植术(CABG)是一项具有挑战性的手术,通常在高危患者群体中进行。由于非体外循环冠状动脉旁路移植术(OPCAB)的侵入性和生理应激降低,因此推测在这些患者中避免使用体外循环(CPB)具有优势。本研究的目的是评估OPCAB是否可以改善再次CABG患者的预后。
通过系统文献综述确定了12项研究,纳入3471例患者。使用随机效应模型对这些研究进行荟萃分析。主要终点是30天和中期死亡率。次要终点是血运重建的完整性、每位患者的平均移植血管数量以及术中转换对死亡率的影响。
OPCAB组观察到30天死亡率显著降低(OR 0.51,95%CI[0.35,0.74]),然而,中期死亡率没有差异。OPCAB组观察到血运重建的完整性和每位患者的平均移植血管数量显著减少。荟萃回归显示,评估从一种技术转换为另一种技术的影响时,30天死亡率没有变化。
非体外循环技术可能会降低部分接受再次CABG患者的早期死亡率;然而,这种情况在中期随访中并未持续。OPCAB也可能导致术中转换,尽管在本研究中这并未影响预后,但这些结果受到可用数据有限的限制。此外,OPCAB可能会增加靶血管血运重建,从而导致血运重建不完整,虽然这在短期预后中没有体现,但需要进行长期随访才能全面评估。